This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2019.
Company Filing History:
2 out of 546 
Years Active: 2019
Title: Christopher Douglas Afdahl: Innovator in Polypeptide Purification
Introduction
Christopher Douglas Afdahl is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the purification of recombinantly produced polypeptides. His innovative methods have the potential to enhance the efficiency of protein purification processes.
Latest Patents
Afdahl holds a patent for a method titled "Purification of recombinantly produced polypeptides." This patent describes a technique for separating a recombinantly produced polypeptide from host cell protein. The method involves loading a clarified cell culture supernatant containing the polypeptide and host cell proteins onto a Protein A chromatography column. Afdahl's approach includes washing the column with a wash buffer that contains a fatty acid with a chain length of at least six carbon atoms, or a fatty acid salt, to effectively remove host cell proteins. The result is the recovery of the desired recombinantly produced polypeptide.
Career Highlights
Afdahl is currently employed at MedImmune Limited, where he applies his expertise in biotechnology and protein purification. His work contributes to the advancement of therapeutic proteins and biopharmaceuticals, which are crucial in modern medicine.
Collaborations
Some of Afdahl's coworkers include Jared Samuel Bee and Liu Tie. Their collaborative efforts in the field of biotechnology further enhance the innovative environment at MedImmune Limited.
Conclusion
Christopher Douglas Afdahl is a prominent inventor whose work in polypeptide purification is paving the way for advancements in biotechnology. His contributions are vital for the development of effective biopharmaceuticals, showcasing the importance of innovation in this field.